Advertisement

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today

A report from Bloomberg News today said that the biopharma heavyweight Bristol Myers Squibb (NYSE: BMY) might be interested in buying Aurinia Pharmaceuticals for an undisclosed sum. The report also noted that Bristol could still walk away from the negotiations. Rumors of a buyout of Aurinia are nothing new.